doi: 10.1093/jac/20.suppl_b.1.
In-vitro activity of roxithromycin against respiratory and skin pathogens
Affiliations
- PMID: 3501424
- DOI: 10.1093/jac/20.suppl_b.1
Item in Clipboard
In-vitro activity of roxithromycin against respiratory and skin pathogens
J Antimicrob Chemother.
1987 Nov.
Abstract
The activity of roxithromycin was determined by a microdilution method, in comparison with erythromycin, spiramycin and josamycin. Roxithromycin and erythromycin showed very similar MICs against staphylococci, Streptococcus pneumoniae, Str. pyogenes and Haemophilus influenzae. In most cases, spiramycin and josamycin appeared similarly or more active. The activity of roxithromycin against Mycoplasma pneumoniae, Legionella spp., Chlamydia psittaci and, to some extent, against Pasteurella spp. was also assessed, by suitable in-vitro methods. Roxithromycin has a promising potential for treating selected skin and respiratory infections.
Similar articles
-
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.Drugs. 1989 Jan;37(1):8-41. doi: 10.2165/00003495-198937010-00002. Drugs. 1989. PMID: 2651088 Review.
-
The comparative in vitro activity of spiramycin and erythromycin against Norwegian bacterial isolates.NIPH Ann. 1986 Dec;9(2):61-3. NIPH Ann. 1986. PMID: 3101004
-
In vitro susceptibility studies with josamycin and erythromycin.Antimicrob Agents Chemother. 1976 Mar;9(3):546-8. doi: 10.1128/AAC.9.3.546. Antimicrob Agents Chemother. 1976. PMID: 4012 Free PMC article.
-
Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.J Antimicrob Chemother. 1987 Nov;20 Suppl B:39-46. doi: 10.1093/jac/20.suppl_b.39. J Antimicrob Chemother. 1987. PMID: 3501426
-
Early studies on in-vitro and experimental activity of spiramycin: a review.J Antimicrob Chemother. 1988 Jul;22 Suppl B:1-11. doi: 10.1093/jac/22.supplement_b.1. J Antimicrob Chemother. 1988. PMID: 3053564 Review.
Cited by
-
Roxithromycin. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.Drugs. 1989 Jan;37(1):8-41. doi: 10.2165/00003495-198937010-00002. Drugs. 1989. PMID: 2651088 Review.
-
Ketolides--the modern relatives of macrolides : the pharmacokinetic perspective.Clin Pharmacokinet. 2009;48(1):23-38. doi: 10.2165/0003088-200948010-00002. Clin Pharmacokinet. 2009. PMID: 19071882 Review.
-
Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.Eur J Epidemiol. 1989 Jun;5(2):146-53. doi: 10.1007/BF00156820. Eur J Epidemiol. 1989. PMID: 2767221
-
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.Antimicrob Agents Chemother. 1994 Feb;38(2):211-6. doi: 10.1128/AAC.38.2.211. Antimicrob Agents Chemother. 1994. PMID: 8192445 Free PMC article.
-
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.Antimicrob Agents Chemother. 1994 Mar;38(3):465-72. doi: 10.1128/AAC.38.3.465. Antimicrob Agents Chemother. 1994. PMID: 8203838 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
